Discovering human immunodeficiency virus mutational pathways using temporal Bayesian networks
| Autor: | Lindsey Fiedler-Cameras, Alma Rios-Flores, Eduardo F. Morales, Pablo Hernandez-Leal, Santiago Ávila-Ríos, Gustavo Reyes-Terán, Felipe Orihuela-Espina, L. Enrique Sucar, Jesus A. Gonzalez |
|---|---|
| Rok vydání: | 2013 |
| Předmět: |
08 Information And Computing Sciences
Anti-HIV Agents HIV Drug Resistance Database Human immunodeficiency virus (HIV) HIV Medicine (miscellaneous) Bayesian network Bayes Theorem Context (language use) Drug resistance Computational biology Biology Virus Replication medicine.disease_cause Bioinformatics 09 Engineering Artificial Intelligence Mutation medicine Graphical model Dynamic Bayesian network Selection (genetic algorithm) Medical Informatics |
| Popis: | ObjectiveThe human immunodeficiency virus (HIV) is one of the fastest evolving organisms in the planet. Its remarkable variation capability makes HIV able to escape from multiple evolutionary forces naturally or artificially acting on it, through the development and selection of adaptive mutations. Although most drug resistance mutations have been well identified, the dynamics and temporal patterns of appearance of these mutations can still be further explored. The use of models to predict mutational pathways as well as temporal patterns of appearance of adaptive mutations could greatly benefit clinical management of individuals under antiretroviral therapy. Methods and materialWe apply a temporal nodes Bayesian network (TNBN) model to data extracted from the Stanford HIV drug resistance database in order to explore the probabilistic relationships between drug resistance mutations and antiretroviral drugs unveiling possible mutational pathways and establishing their probabilistic-temporal sequence of appearance. ResultsIn a first experiment, we compared the TNBN approach with other models such as static Bayesian networks, dynamic Bayesian networks and association rules. TNBN achieved a 64.2% sparser structure over the static network. In a second experiment, the TNBN model was applied to a dataset associating antiretroviral drugs with mutations developed under different antiretroviral regimes. The learned models captured previously described mutational pathways and associations between antiretroviral drugs and drug resistance mutations. Predictive accuracy reached 90.5%. ConclusionOur results suggest possible applications of TNBN for studying drug-mutation and mutation-mutation networks in the context of antiretroviral therapy, with direct impact on the clinical management of patients under antiretroviral therapy. This opens new horizons for predicting HIV mutational pathways in immune selection with relevance for antiretroviral drug development and therapy plan. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|